Vincerx Pharma Inc (VINC)

Stock price, financials, and technical signals for Vincerx Pharma Inc (VINC).

$1.50

-0.06

(-3.85%)

As of 01/31/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

VINC Performance Snapshot


1-Week Chg

-41.91%

1-Month Chg

-76.92%

3-Month Chg

-78.57%

6-Month Chg

-87.81%

1-Year Chg

-93.85%

Year-To-Date Chg

-68.13%

Beta 1-Year

1.54

Beta 5-Year

0.92

Volatility (10-Day)

24.60%

VINC Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-01-31

$1.58

$0.08 (5.33%)

$1.51

$1.65

$1.44

$1.56

374.44K ($591.61K)

2025-01-30

$1.50

-$0.06 (-3.85%)

$1.51

$1.65

$1.40

$1.52

996.71K ($1.50M)

2025-01-29

$1.56

-$0.09 (-5.45%)

$1.97

$2.00

$1.45

$1.67

18.12M ($28.27M)

2025-01-28

$1.65

-$0.34 (-17%)

$2

$2

$1.62

$1.76

415.74K ($685.97K)

2025-01-27

$1.99

-$0.09 (-4.42%)

$2

$2.03

$1.95

$1.99

125.45K ($249.40K)

2025-01-24

$2.08

-$0.50 (-19.44%)

$2.16

$2.20

$2

$2.09

376.24K ($782.57K)

2025-01-23

$2.58

$0.35 (15.89%)

$2.34

$2.67

$2.24

$2.50

423.48K ($1.09M)

2025-01-22

$2.23

-$0.72 (-24.47%)

$2.63

$2.70

$2.00

$2.31

432.54K ($963.70K)

2025-01-21

$2.95

-$0.10 (-3.15%)

$3.01

$3.04

$2.81

$2.93

165.01K ($486.77K)

2025-01-17

$3.05

$0.24 (8.71%)

$3.10

$3.13

$2.84

$3.00

135.48K ($412.67K)

VINC Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $3.03M

    -80.02%

  • Total assets

    $14.95M

    -43.12%

  • Total liabilities

    $5.84M

    -44.58%

  • Total investments

    $7.14M

    24.81%

  • Shareholders' equity

    $9.11M

    -42.14%

  • Book value per share

    $0.20

    -73.00%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $0

    0%

  • Net income

    -$7.84M

    19.27%

  • Operating expense

    $7.79M

    -24.46%

  • Gross profit

    $0

    0%

  • EBITDA

    -$7.57M

    20.01%

  • Earnings per share

    -$0.17

    63.04%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    -$4.98M

    -159.27%

  • Cash from operations

    -$6.38M

    4.00%

  • Cash from investing

    $1.37M

    -90.88%

  • Cash from financing

    $0

    0%

  • Free cash flow

    -$6.38M

    4.00%

  • Free cash flow per share

    -$0.14

    54.98%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $21.25M

    -1.62%

  • Enterprise value

    $15.17M

    -15.09%

  • Shares outstanding

    29.67M

    38.78%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    2.17

    -16.01%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.